Search results
Results from the WOW.Com Content Network
Spinal muscular atrophy (SMA) is a rare neuromuscular disorder that results in the loss of motor neurons and progressive muscle wasting. [3] [4] [5] It is usually diagnosed in infancy or early childhood and if left untreated it is the most common genetic cause of infant death. [6]
The Singapore Medical Association (abbreviated SMA) is a professional association representing the interests of medical professionals in Singapore. It was established on September 15, 1959, replacing the Malaya Branch of the British Medical Association . [ 2 ]
Spinal muscular atrophies (SMAs) are a genetically and clinically heterogeneous group of rare debilitating disorders characterised by the degeneration of lower motor neurons (neuronal cells situated in the anterior horn of the spinal cord) and subsequent atrophy (wasting) of various muscle groups in the body. [1]
SMA, several medical abbreviations; SMA 12, SMA 20 and SMAC, previous names of Comprehensive metabolic panel blood tests; α-SMA or ACTA2, an actin protein; Spinal muscular atrophy, a severe neuromuscular disorder; Spinal muscular atrophies, a heterogeneous group of rare disorders; Superior mesenteric artery; Supplementary motor area, of the ...
SMA Solar Technology AG (meaning System, Mess and Anlagentechnik) is a German solar energy equipment supplier founded in 1981 and headquartered in Niestetal, Northern Hesse, Germany. SMA is a producer and manufacturer of solar inverters for photovoltaics systems with grid connection, off-grid power supply and backup operations.
The supplementary motor area (SMA) is a part of the motor cortex of primates that contributes to the control of movement. It is located on the midline surface of the hemisphere just in front of (anterior to) the primary motor cortex leg representation. In monkeys, the SMA contains a rough map of the body. In humans, the body map is not apparent.
Nusinersen, [7] marketed as Spinraza, [4] is a medication used in treating spinal muscular atrophy (SMA), a rare neuromuscular disorder. [8] [4] In December 2016, it became the first approved drug used in treating this disorder.
Spinal muscular atrophy with progressive myoclonic epilepsy (SMA-PME), sometimes called Jankovic–Rivera syndrome, is a very rare neurodegenerative disease whose symptoms include slowly progressive muscle loss (), predominantly affecting proximal muscles, combined with denervation and myoclonic seizures. [1]